2018
DOI: 10.1186/s12881-017-0512-6
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac manifestations of PRKAG2 mutation

Abstract: BackgroundThe Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) cardiac syndrome is characterized by glycogen accumulation in the cardiac tissue. The disease presents clinically with hypertrophic cardiomyopathy (HCM), and it is often associated with conduction abnormalities.Case presentationA 23 year-old female with history of Wolff-Parkinson-White (WPW) and HCM presented for evaluation after an episode of Non-ST Elevation Myocardial Infarction (NSTEMI). The patient was found to have severe c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
30
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(33 citation statements)
references
References 16 publications
(20 reference statements)
1
30
0
1
Order By: Relevance
“…Expression data showing downregulation of AMPK regulator PRKAG3 could be indicative of altered glycogen storage, with glycogen storage disease and PRKAG2 (isoform of PRKAG3 ) mutation seen in some cases of cardiomyopathy (Porto et al ; Banankhah et al ). To see whether any phenotype of glycogen storage was present, glycogen deposition was analysed by periodic acid‐Schiff stain with diastase (PAS‐D) at HH35 in OFT‐banded and sham hearts ( n = 3 per group).…”
Section: Resultsmentioning
confidence: 99%
“…Expression data showing downregulation of AMPK regulator PRKAG3 could be indicative of altered glycogen storage, with glycogen storage disease and PRKAG2 (isoform of PRKAG3 ) mutation seen in some cases of cardiomyopathy (Porto et al ; Banankhah et al ). To see whether any phenotype of glycogen storage was present, glycogen deposition was analysed by periodic acid‐Schiff stain with diastase (PAS‐D) at HH35 in OFT‐banded and sham hearts ( n = 3 per group).…”
Section: Resultsmentioning
confidence: 99%
“…Different studies show prevalences of ARMC5 mutations ranging from 19.6% to 55%, mostly sporadic cases [ 3 , 4 , 14 ]. ARMC5 likely functions as a tumor suppressor gene, and somatic mutations have been detected in addition to the germline mutations in patients with PBMAH, supporting the “two-hit” model for ARMC5 as a tumor suppressor gene [ 3 , 15 , 16 ]. The occurrence of intracranial meningiomas has also been associated with PBMAH, suggesting a possible role of ARMC5 for the development of other neoplasia [ 17 ].…”
Section: Introductionmentioning
confidence: 89%
“…We annotated a significant promoter switch in PRKAG2, a gene linked to hypertrophic cardiomyopathy and critical to heart metabolism. [36][37][38] Three major PRKAG2 promoters were identified, encoding three different isoforms-g2a, g2-3b, and g2b ( Figure 5D).…”
Section: Correlation Of Cage-sequencing and Rna-sequencingmentioning
confidence: 99%